Hidemasa Oh

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Eight-Year Outcomes of Cardiosphere-Derived Cells in Single Ventricle Congenital Heart Disease.

Eight-Year Outcomes of Cardiosphere-Derived Cells in Single Ventricle Congenital Heart Disease.

Journal: Journal of the American Heart Association

Published: November 11, 2024

Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy.

Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy.

Journal: Science translational medicine

Published: February 17, 2020

Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease.

Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease.

Journal: Circulation research

Published: October 29, 2017

Transcoronary cell infusion with the stop-flow technique in children with single-ventricle physiology.

Transcoronary cell infusion with the stop-flow technique in children with single-ventricle physiology.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: May 31, 2017

Cell Therapy Trials in Congenital Heart Disease.

Cell Therapy Trials in Congenital Heart Disease.

Journal: Circulation research

Published: April 15, 2017

Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial.

Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial.

Journal: Circulation research

Published: November 01, 2016

Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases.

Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases.

Journal: Journal of cardiology

Published: April 08, 2016

Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.

Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.

Journal: The Journal of thoracic and cardiovascular surgery

Published: March 23, 2015

Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.

Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.

Journal: Circulation research

Published: November 19, 2014

Stem cell therapies in patients with single ventricle physiology.

Stem cell therapies in patients with single ventricle physiology.

Journal: Methodist DeBakey cardiovascular journal

Published: August 13, 2014

Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome.

Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome.

Journal: PloS one

Published: May 16, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026